These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2383524)

  • 1. Effect of dexfenfluramine on gastric emptying of a mixed solid-liquid meal in obese subjects.
    Horowitz M; Maddox A; Wishart J; Vernon-Roberts J; Chatterton B; Shearman D
    Br J Nutr; 1990 May; 63(3):447-55. PubMed ID: 2383524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenfluramine delays gastric emptying of solid food.
    Horowitz M; Collins PJ; Tuckwell V; Vernon-Roberts J; Shearman DJ
    Br J Clin Pharmacol; 1985 Jun; 19(6):849-51. PubMed ID: 4027128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric and oesophageal emptying in obesity.
    Maddox A; Horowitz M; Wishart J; Collins P
    Scand J Gastroenterol; 1989 Jun; 24(5):593-8. PubMed ID: 2762759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexfenfluramine treatment of obesity: a double blind trial with post trial follow up.
    O'Connor HT; Richman RM; Steinbeck KS; Caterson ID
    Int J Obes Relat Metab Disord; 1995 Mar; 19(3):181-9. PubMed ID: 7780494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slowed gastric evacuation accounts for the reduction of food intake by anorectic drugs.
    Jonderko K; Kucio C; Skrzypek D
    Eur J Clin Nutr; 1988 Jul; 42(7):627-31. PubMed ID: 3066620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dexfenfluramine treatment on body weight and postprandial thermogenesis in obese subjects. A double-blind placebo-controlled study.
    Lafreniere F; Lambert J; Rasio E; Serri O
    Int J Obes Relat Metab Disord; 1993 Jan; 17(1):25-30. PubMed ID: 8383638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of dexfenfluramine on weight loss and cardiovascular risk factors in female patients with upper and lower body obesity.
    Ditschuneit HH; Flechtner-Mors M; Adler G
    J Cardiovasc Risk; 1996 Aug; 3(4):397-403. PubMed ID: 8946272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged weight loss with dexfenfluramine treatment in obese patients.
    Finer N; Craddock D; Lavielle R; Keen H
    Diabete Metab; 1987; 13(6):598-602. PubMed ID: 3329122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of increasing the caloric/osmotic content of the liquid component of a mixed solid and liquid meal on gastric emptying in obese subjects.
    Horowitz M; Collins PJ; Shearman DJ
    Hum Nutr Clin Nutr; 1986 Jan; 40(1):51-6. PubMed ID: 3957711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 6 months therapy with dexfenfluramine in obese patients: studies in the United Kingdom.
    Finer N; Craddock D; Lavielle R; Keen H
    Clin Neuropharmacol; 1988; 11 Suppl 1():S179-86. PubMed ID: 3052816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cholestyramine on gallbladder and gastric emptying in obese and lean subjects.
    Portincasa P; Di Ciaula A; Palmieri V; Van Berge-Henegouwen GP; Palasciano G
    Eur J Clin Invest; 1995 Oct; 25(10):746-53. PubMed ID: 8557061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight loss and delayed gastric emptying following a South American herbal preparation in overweight patients.
    Andersen T; Fogh J
    J Hum Nutr Diet; 2001 Jun; 14(3):243-50. PubMed ID: 11424516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial.
    Halawi H; Khemani D; Eckert D; O'Neill J; Kadouh H; Grothe K; Clark MM; Burton DD; Vella A; Acosta A; Zinsmeister AR; Camilleri M
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):890-899. PubMed ID: 28958851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cisapride on gastric and esophageal emptying in progressive systemic sclerosis.
    Horowitz M; Maddern GJ; Maddox A; Wishart J; Chatterton BE; Shearman DJ
    Gastroenterology; 1987 Aug; 93(2):311-5. PubMed ID: 3596167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities of gastric emptying in obese patients.
    Horowitz M; Collins PJ; Cook DJ; Harding PE; Shearman DJ
    Int J Obes; 1983; 7(5):415-21. PubMed ID: 6642853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of anti-obesity drugs promoting energy expenditure, yohimbine and ephedrine, on gastric emptying in obese patients.
    Jonderko K; Kucio C
    Aliment Pharmacol Ther; 1991 Aug; 5(4):413-8. PubMed ID: 1777550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of dexfenfluramine on eating behavior and body weight of obese patients: results of a field study of Isomeride in Austrian general practice].
    Geyer G; Haidinger G; Francesconi M; Langmayr N; Prager R; Schoberberger R; Toplak H; von Kalckreuth G; Kunze M
    Acta Med Austriaca; 1995; 22(5):95-101; 104-9. PubMed ID: 8651045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons between the effects of 5-HT and DL-fenfluramine on food intake and gastric emptying in the rat.
    Francis J; Critchley D; Dourish CT; Cooper SJ
    Pharmacol Biochem Behav; 1995 Apr; 50(4):581-5. PubMed ID: 7617704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [International study of the effect of dexfenfluramine in obesity (ISIS): 6 months' results].
    Guy-Grand B; Apfelbaum M; Crepaldi G; Gries A; Lefebvre P; Turner P
    Rev Med Interne; 1989; 10(3):271-7. PubMed ID: 2669089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a cellulose-containing weight-loss supplement on gastric emptying and sensory functions.
    Berthold HK; Unverdorben S; Degenhardt R; Unverdorben M; Gouni-Berthold I
    Obesity (Silver Spring); 2008 Oct; 16(10):2272-80. PubMed ID: 18719632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.